ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag techniques epigenetics opinion infectious disease

Mapping Disease
Ed Yong | Apr 28, 2013 | 4 min read
Online tools could help to improve our patchy knowledge of the whereabouts of infectious diseases.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Opinion: Target the Vector
Mirco Junker | Jun 28, 2016 | 3 min read
Officials’ increased emphasis on mosquito control could benefit public health efforts beyond the ongoing Zika outbreak. 
illustration of people using social media on various electronic devices
Can Social Media Inform Public Health Efforts?
Emma Yasinski | Jan 6, 2020 | 9 min read
Scientists are using social media to track diseases and understand how people respond to them.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
 coronavirus covid-19 sars-cov-2 diagnostic test real-time pcr antibodies cdc
How SARS-CoV-2 Tests Work and What’s Next in COVID-19 Diagnostics
Bianca Nogrady | Mar 3, 2020 | 6 min read
Current methods to detect infections of the novel coronavirus rely on identifying particular genetic sequences, but new assays are being developed to meet the growing demand for rapid answers.
an artistic rendering of CRISPR/Cas9
Ten Years of CRISPR
Sophie Fessl, PhD | Jun 28, 2022 | 7 min read
This month marks ten years since CRISPR-Cas9 was repurposed as a gene editing system, so we’re looking back at what has been accomplished in a decade of CRISPR editing.
How Some Vaccines Protect Against More than Their Targets
Shawna Williams | Nov 1, 2020 | 10+ min read
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
Cloning Capsized?
Ted Agres | Aug 19, 2001 | 10+ min read
Biopharmaceutical researchers fear how pending federal legislation outlawing the cloning of human cells will restrict their abilities to find cures for major degenerative diseases.1,2 Some also see lawmakers impinging on established nonhuman cloning techniques essential for the discovery of new drugs and therapies. The source of all this worry? The US House of Representatives passed July 31 by a wide margin a bill (H.R. 2505) sponsored by Reps. David Weldon (R-Fla.) and Bart Stupak (D-Mich.) th
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.

Run a Search

ADVERTISEMENT